Insight

Hind Rafei: Brief Updates on CAR-Natural Killer Cell Therapy for Cancer

Hind Rafei and Katy Rezvani

Dec 9, 2024, 13:23

Hind Rafei: Brief Updates on CAR-Natural Killer Cell Therapy for Cancer

Hind Rafei, Assistant Professor in the Department of Stem Cell Transplantation and Cellular Therapy at MD Anderson Cancer Center, shared a recent article on X:

“Please check out our recent in a Nutshell article for brief updates on CAR-Natural killer cell therapy for cancer.

Lots of new exciting frontiers in the field.”

Title: Advances and challenges in chimeric antigen receptor-natural killer cell immunotherapy for cancer

Authors: Hind Rafei and Katayoun Rezvani

More posts featuring Hind Rafei.

antigen receptor British Journal of Haematology cancer Hind Rafei immunotherapy Journal of Haematology Katayoun Rezvani MD Anderson Cancer Center Natural Killer cell OncoDaily Oncology Stem Cell Transplantation therapy

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage